Hi CosmoRings,
In short Morgans do not know what they are talking about. If you look at the studies it is just not the case. They should actually do some research before they dribble false information into the market.
IPPS is not a majic bullet for everyone however if you listen to some of the people in this forum and the AFL footballers etc who tell their stories of being able to play competitive sport again, others who can walk again the proof lies there. I think the phase 3 studies will reaffirm the existing levels however we will also know alot more about the DMOD impacts of IPPS which leads to stopping or reversing the OA. This is where the real fun will begin IMO.
PAR at present are trying to get though Phase 3 by picking a proven benchmark (based on completed studies) PAIN. I think they will expand these studies and much more work will be done on IPPS going forward to prove its DMOD.
- Forums
- ASX - By Stock
- PAR
- Ann: Consistent pain reduction and improvement in function data
Ann: Consistent pain reduction and improvement in function data, page-97
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 118621 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 0.240 |
4 | 27745 | 0.235 |
1 | 25000 | 0.230 |
5 | 41756 | 0.225 |
7 | 59930 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 74601 | 4 |
0.255 | 50000 | 1 |
0.260 | 21333 | 2 |
0.265 | 69367 | 4 |
0.270 | 53000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online